TY - JOUR
T1 - Recommendations for the use of biologic (TNF-α blocking) agents in the treatment of rheumatoid arthritis in Italy
AU - Valesini, Guido
AU - Montecucco, Carlomaurizio
AU - Cutolo, Maurizio
PY - 2006/7
Y1 - 2006/7
N2 - The present report is devoted to drawing up and disseminating specific recommendations for the use of anti-TNF-α therapies in patients with rheumatoid arthritis (RA) in Italy. The document reports and discusses the published literature concerning the criteria for inclusion, assessment of response and for withdrawal of treatment with TNF blocking agents in RA. Several specific points concerning more sensitive warnings are discussed: tuberculosis, hepatitis, lymphoma, and cardiovascular risk and induction of autoimmunity. The recommendations are summarized in an 8-point table approved by the executive committee of the Italian Societyfor Rheumatology.
AB - The present report is devoted to drawing up and disseminating specific recommendations for the use of anti-TNF-α therapies in patients with rheumatoid arthritis (RA) in Italy. The document reports and discusses the published literature concerning the criteria for inclusion, assessment of response and for withdrawal of treatment with TNF blocking agents in RA. Several specific points concerning more sensitive warnings are discussed: tuberculosis, hepatitis, lymphoma, and cardiovascular risk and induction of autoimmunity. The recommendations are summarized in an 8-point table approved by the executive committee of the Italian Societyfor Rheumatology.
KW - Anti-TNF
KW - Biological agents
KW - Management
KW - Recommendations
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=33748556210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748556210&partnerID=8YFLogxK
M3 - Article
C2 - 16956432
AN - SCOPUS:33748556210
SN - 0392-856X
VL - 24
SP - 413
EP - 423
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
IS - 4
ER -